Literature DB >> 34900078

Chromophobe renal cell carcinoma-like thyroid carcinoma: possible misdiagnosis as metastatic renal cell carcinoma.

Hee Jung Kwon1, Min Hye Jang1.   

Abstract

To date, multiple thyroid cancer variants have been reported. Herein, we report a rare case of chromophobe renal cell carcinoma-like thyroid carcinoma (CRETHCA) in a 60-year-old woman, for which the morphologic findings resembled those of chromophobe renal cell carcinoma (ChRCC). ChRCC of the kidney is characterized by large polygonal tumor cells with distinct cell borders, perinuclear clearing, multiple binucleate cells, and strongly positive immunostaining for paired box gene 8 (PAX8) and carbonic anhydrase IX (CA IX). In our case, the thyroid gland tumor was incidentally detected by routine medical screening without sufficient medical information; it showed similar histology and immunohistochemical features to ChRCC and was initially misdiagnosed as metastatic ChRCC. Additional tests, including kidney computed tomography and positron emission tomography, revealed no abnormalities in the patient's kidney; therefore, we diagnosed the tumor as CRETHCA. Focal weak staining for thyroid transcription factor 1 (TTF-1) was the only supporting evidence that it was a primary thyroid neoplasm. To the best of our knowledge, this is the second report of CRETHCA in literature. This novel variant is very difficult to distinguish from metastatic ChRCC and can be a diagnostic challenge for pathologists. Further studies of similar cases should be done to define this new entity. IJCEP
Copyright © 2021.

Entities:  

Keywords:  Chromophobe renal cell carcinoma; misdiagnosis; poorly differentiated carcinoma; thyroid carcinoma

Year:  2021        PMID: 34900078      PMCID: PMC8661068     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

2.  Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion-a case report.

Authors:  M Flader; P Kurzawa; J Maldyk; J Sygut; J Harasymczuk; A Kropinska; D Handkiewicz-Junak; B Jarzab; K Kotulska; M Niedziela
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

3.  Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.

Authors:  Juan Guo; Maria S Tretiakova; Megan L Troxell; Adeboye O Osunkoya; Oluwole Fadare; Ankur R Sangoi; Steven S Shen; Antonio Lopez-Beltran; Rohit Mehra; Amer Heider; John P Higgins; Lara R Harik; Xavier Leroy; Anthony J Gill; Kiril Trpkov; Steven C Campbell; Christopher Przybycin; Cristina Magi-Galluzzi; Jesse K McKenney
Journal:  Am J Surg Pathol       Date:  2014-11       Impact factor: 6.394

4.  A comprehensive analysis of PAX8 expression in human epithelial tumors.

Authors:  Anna R Laury; Ruth Perets; Huiying Piao; Jeffrey F Krane; Justine A Barletta; Christopher French; Lucian R Chirieac; Rosina Lis; Massimo Loda; Jason L Hornick; Ronny Drapkin; Michelle S Hirsch
Journal:  Am J Surg Pathol       Date:  2011-06       Impact factor: 6.394

Review 5.  Spindle epithelial tumor with thymus-like differentiation (SETTLE): a distinctive malignant thyroid neoplasm with significant metastatic potential.

Authors:  W Cheuk; A A Jacobson; J K Chan
Journal:  Mod Pathol       Date:  2000-10       Impact factor: 7.842

6.  Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex.

Authors:  Mitsuyoshi Hirokawa; Akira Miyauchi; Minoru Kihara; Takumi Kudo; Yuko Hashimoto; Shinichi Suzuki; Tsutomu Daa; Huy Gia Vuong; Norisato Mitsutake
Journal:  Endocr J       Date:  2017-07-06       Impact factor: 2.349

Review 7.  Comprehensive review of chromophobe renal cell carcinoma.

Authors:  Rohan Garje; Dean Elhag; Hesham A Yasin; Luna Acharya; Daniel Vaena; Laila Dahmoush
Journal:  Crit Rev Oncol Hematol       Date:  2021-03-19       Impact factor: 6.312

Review 8.  Value of PAX 8 immunostaining in tumor diagnosis: a review and update.

Authors:  Nelson G Ordóñez
Journal:  Adv Anat Pathol       Date:  2012-05       Impact factor: 3.875

Review 9.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

10.  Chromophobe renal cell carcinoma: analysis of 61 cases.

Authors:  Michaël Peyromaure; Vincent Misrai; Nicolas Thiounn; Annick Vieillefond; Marc Zerbib; Thierry A Flam; Bernard Debré
Journal:  Cancer       Date:  2004-04-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.